peptides

  • Human PRAME 61-75, FDGRHSQTLKAMVQA

    Human PRAME 61-75, FDGRHSQTLKAMVQA

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FDGRHSQTLKAMVQA-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 63-70, QLLALLPSL

    Human PRAME 63-70, QLLALLPSL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-QLLALLPSL-OH Specifications: 9mer peptide as TFA salt

  • Human PRAME 65-79, HSQTLKAMVQAWPFT

    Human PRAME 65-79, HSQTLKAMVQAWPFT

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-HSQTLKAMVQAWPFT-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 69-83, LKAMVQAWPFTCLPL

    Human PRAME 69-83, LKAMVQAWPFTCLPL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LKAMVQAWPFTCLPL-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 73-87, VQAWPFTCLPLGVLM

    Human PRAME 73-87, VQAWPFTCLPLGVLM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VQAWPFTCLPLGVLM-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 77-91, PFTCLPLGVLMKGQH

    Human PRAME 77-91, PFTCLPLGVLMKGQH

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PFTCLPLGVLMKGQH-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 81-95, LPLGVLMKGQHLHLE

    Human PRAME 81-95, LPLGVLMKGQHLHLE

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LPLGVLMKGQHLHLE-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 85-99, VLMKGQHLHLETFKA

    Human PRAME 85-99, VLMKGQHLHLETFKA

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VLMKGQHLHLETFKA-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 89-103, GQHLHLETFKAVLDG

    Human PRAME 89-103, GQHLHLETFKAVLDG

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-GQHLHLETFKAVLDG-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 9-23, SIQSRYISMSVWTSP

    Human PRAME 9-23, SIQSRYISMSVWTSP

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SIQSRYISMSVWTSP-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 93-107, HLETFKAVLDGLDVL

    Human PRAME 93-107, HLETFKAVLDGLDVL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-HLETFKAVLDGLDVL-OH Specifications: 15mer peptide as TFA salt

  • Human PRAME 97-111, FKAVLDGLDVLLAQE

    Human PRAME 97-111, FKAVLDGLDVLLAQE

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Melanoma Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Melanoma antigen preferentially expressed in tumors Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FKAVLDGLDVLLAQE-OH Specifications: 15mer peptide as TFA salt

  • Human PREX1 protein isoform X1 604-612, EEALGLYHW

    Human PREX1 protein isoform X1 604-612, EEALGLYHW

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Immunogenic Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1 (PREX1) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-EEALGLYHW-OH Specifications: 9mer peptide as TFA salt

  • Human Probable ATP-dependent RNA helicase DDX17  225-233, YLLPAIVHI

    Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Leukemia Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Probable protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YLLPAIVHI-OH Specifications: 9mer peptide as TFA salt

  • Human Probable ATP-dependent RNA helicase DDX20  688-696, TPVDDRISL

    Human Probable ATP-dependent RNA helicase DDX20 688-696, TPVDDRISL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Immunogenic Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Probable protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TPVDDRISL-OH Specifications: 9mer peptide as TFA salt

  • Human Probable ribonuclease ZC3H12D  321-330, APREPFAHSL

    Human Probable ribonuclease ZC3H12D 321-330, APREPFAHSL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Immunogenic Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Protein Name: Probable protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-APREPFAHSL-OH Specifications: 10mer peptide as TFA salt